Stimulating the brain's self-control center via rTMS reduces smoking by 11 cigarettes a day, outperforming reward-suppression tactics.

The line between "my body is speaking" and "I might need a blood test" is thinner than you think.

A new study suggests GLP-1 weight-loss drugs may be able to do more than curb appetite. Here's what researchers found.

The data shows that the drugs triggered activity in the central amygdala that reduced dopamine release into the brain's reward circuitry.

UCSF experts share their research on medications’ potential to slow or reduce risk of dementia and to treat the triggers that ...

Chips, Doritos, fries, ramen, nachos, pizza, jerky, cheese, pickles—does it seem like your body is constantly begging for ...

It turns out that giving into your cravings for ice cream and chips during your period might intensify the very symptoms you ...

Experts are already treating addicted people with at-home neuromodulation devices to control cravings, and the future is ...

Addiction hits hard. It steals lives and breaks families. Yet, many see it as a sign of weak will. What if we flip that view? Addiction is a brain disorder, not a moral slip. This piece clears up why ...

Discover what chocolate really does to your brain after a breakup, from mood boosts to emotional comfort, and why cravings ...

A study has found that an emerging class of GLP-1 weight-loss drugs suppresses eating for pleasure, or hedonic feeding, in ...